Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
Matthew Kearney, Lauren Franks, Shing Yip Lee, Amy Tiersten, Della Makower, Tessa Cigler, Prabhjot S. Mundi, Dow-Chung Chi, Anupama Goel, Pam Klein, Eleni Andreopoulou, Joseph A. Sparano, Meghna S. Trivedi, Melissa Accordino, Andrea Califano, Dawn L. Hershman, José Sandro Pereira da Silva, Kevin Kalinsky
Topics & Concepts
TrastuzumabRuxolitinibMedicineInternal medicineOncologyMetastatic breast cancerBreast cancerPhases of clinical researchCancerClinical trialMyelofibrosisBone marrowHER2/EGFR in Cancer ResearchCytokine Signaling Pathways and InteractionsRadiopharmaceutical Chemistry and Applications